The Cooper Companies, Inc. $COO Shares Sold by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd lessened its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 32,506 shares of the medical device company’s stock after selling 722 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Cooper Companies were worth $2,313,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. JPMorgan Chase & Co. grew its holdings in Cooper Companies by 3.4% during the first quarter. JPMorgan Chase & Co. now owns 5,177,008 shares of the medical device company’s stock worth $436,681,000 after acquiring an additional 172,485 shares during the period. Goldman Sachs Group Inc. grew its holdings in Cooper Companies by 17.0% in the first quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company’s stock valued at $399,340,000 after purchasing an additional 686,751 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Cooper Companies by 12.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,954,877 shares of the medical device company’s stock valued at $333,595,000 after purchasing an additional 425,400 shares during the last quarter. Millennium Management LLC grew its holdings in Cooper Companies by 36.0% in the first quarter. Millennium Management LLC now owns 2,577,416 shares of the medical device company’s stock valued at $217,405,000 after purchasing an additional 682,166 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Cooper Companies by 15.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,121,835 shares of the medical device company’s stock valued at $178,977,000 after purchasing an additional 284,943 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Performance

Cooper Companies stock opened at $68.17 on Monday. The stock’s 50-day moving average is $70.66 and its 200-day moving average is $74.93. The company has a market cap of $13.55 billion, a price-to-earnings ratio of 33.58, a price-to-earnings-growth ratio of 1.79 and a beta of 0.97. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $111.44.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.03. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The company’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period last year, the business posted $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies announced that its Board of Directors has approved a stock repurchase plan on Wednesday, September 17th that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the medical device company to purchase up to 15.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its stock is undervalued.

Insider Transactions at Cooper Companies

In other news, COO Gerard H. Warner III acquired 1,450 shares of the business’s stock in a transaction dated Friday, September 5th. The shares were bought at an average cost of $69.23 per share, for a total transaction of $100,383.50. Following the acquisition, the chief operating officer directly owned 18,319 shares in the company, valued at $1,268,224.37. This trade represents a 8.60% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Brian G. Andrews bought 1,525 shares of the company’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were bought at an average price of $65.68 per share, for a total transaction of $100,162.00. Following the completion of the acquisition, the executive vice president owned 22,191 shares in the company, valued at approximately $1,457,504.88. This trade represents a 7.38% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have purchased 15,975 shares of company stock valued at $1,079,566. 1.98% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms have weighed in on COO. BNP Paribas raised Cooper Companies from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 22nd. Mizuho lowered their target price on Cooper Companies from $105.00 to $90.00 and set an “outperform” rating on the stock in a report on Wednesday, July 16th. Morgan Stanley set a $76.00 target price on Cooper Companies and gave the company an “equal weight” rating in a report on Thursday, August 28th. Piper Sandler lowered their target price on Cooper Companies from $105.00 to $83.00 and set an “overweight” rating on the stock in a report on Thursday, August 28th. Finally, BNP Paribas Exane raised Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 price objective on the stock in a research note on Tuesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $86.64.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.